Extracellular matrix remodelling: the role of matrix metalloproteinases

By I. Stamenkovic. Journal of Pathology, 2003

1,159 citations recorded by the source corpus.

Subfields: Cancer Research, Immunology and Allergy, Oncology

View Paper: https://www.semanticscholar.org/paper/591fedd9256f8688b3ef0b02ece570737bde31ac

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

In Cancer Research

1. P. Barnes
2. B. Bauer
3. A. Hartz
4. R. Rempe
5. Hao-Hsiu Huang

In Immunology and Allergy

1. P. Barnes
2. R. Alon
3. B. Bauer
4. A. Hartz
5. A. Luster
6. R. Rempe
7. Hao-Hsiu Huang

In Oncology

1. P. Barnes
2. B. Bauer
3. A. Hartz
4. A. Luster
5. R. Rempe
6. Hao-Hsiu Huang

Citations in the corpus

• Fibrosis and Adipose Tissue Dysfunction (2013, background): “While this type of collagen has been considered to be resistant to proteolysis, several matrix metalloproteinases (MMPs) have been reported to digest it under certain circumstances during development or chronic disease progression (Stamenkovic, 2003).”
• Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers (2016, background): “This is done indirectly by activating enzymes that act on signaling molecules such as cytokines, cell surface receptors, cell–cell adhesion molecules, or clotting factors.(59,60) Alternatively, MMPs directly activate neuroinflammatory pathways.”
• Mediators of Chronic Obstructive Pulmonary Disease (2004, background): “MMPs are a large family of zinc-dependent proteinases that regulate the destruction of extracellular matrix components (Stamenkovic, 2003).”
• Immune cell migration in inflammation: present and future therapeutic targets (2005, background): “Distinct types of inflammatory cells may differentially use their membrane-bound and secreted proteases as well as glycosaminoglycan-degrading enzymes to remodel and penetrate ECM barriers, especially while migrating through the tightly interwoven basal lamin”
• Matrix Metalloproteinase-9 (MMP-9) as a Cancer Biomarker and MMP-9 Biosensors: Recent Advances (2018, background): “MMP-9 can degrade many extracellular matrix (ECM) proteins through proteolytic cleavage to regulate ECM remodeling (Figure 2) [3,20,44,45].”